Navigation Links
Nplate(TM) (Romiplostim) Receives Positive Opinion for Marketing Authorisation in the European Union
Date:11/21/2008

ups when treated with Nplate. Additionally, patients treated with Nplate were able to reduce or discontinue concomitant ITP and emergency medications which are often not well tolerated or whose effects are transient (i.e. corticosteroids, IVIG, Win-Rho Anti-D therapy).

Upon completion of the Phase 3 studies almost 90 percent of patients elected to subsequently enroll into the romiplostim long term extension study which demonstrated that, after three years, Nplate continued to effectively increase and sustain platelet counts. In this open label long term extension study some patients were treated for over 156 weeks and in the interim analysis the median treatment duration in this study is 65 weeks.

About Adult ITP

In patients with ITP, platelets -- or blood cells needed to prevent bleeding -- are destroyed by the patient's own immune system. Low platelet counts leave adult ITP patients open to sudden serious bleeding events, making it impossible to arrest blood flow. The risk for serious bleeding events increases when platelet counts drop to less than 30,000 platelets per microliter; normal counts range from 150,000 to 400,000 platelets per microliter. ITP has historically been considered a disease of platelet destruction although recent data suggest that the body's natural platelet production processes in ITP are unable to compensate for low levels of platelets in the blood. Increasing the rate of platelet production may address low platelet levels associated with ITP.

Currently available treatments (i.e., corticosteroids, immunoglobulins) have limited application due to poor tolerability or transient effects. Surgical therapy (removal of the spleen) is also available to adult patients with chronic ITP, but does not work in all cases. Currently, there are 140,000 treated chronic ITP patients in Europe and the U.S. ITP affects about twice as many adult women as men.

Abo
'/>"/>

SOURCE Amgen
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. J. Craig Venter, Ph.D. Receives Double Helix Medal from Cold Spring Harbor Laboratory
2. Medarex Receives Milestone Payment for Investigational Antibody Targeting Integrin Receptors
3. Abbott Receives Complete Response Letter From FDA for Controlled-Release Hydrocodone With Acetaminophen
4. Life Recovery Systems Receives NIH Grant to Study Expanded Use of Its ThermoSuit System
5. Berlin Hearts EXCOR(R) Pediatric Receives Unconditional Investigational Device Exemption (IDE) Approval
6. Neuronascent, Inc. Receives Multiple Fundings for Its Neurogenesis Therapeutic Programs
7. TriReme Medical Inc. Receives CE Marking for Antares(TM) Coronary Stent System
8. Anthera Completes Special Protocol Assessment With FDA and Receives EMEA Scientific Advice on Development Path Toward Varespladib Approval
9. AstraZeneca Receives Six Months Pediatric Exclusivity for CASODEX(R) (bicalutamide) from the FDA
10. Helix Receives Approval to Open Sites in Germany for its Ongoing Clinical Trial With Topical Interferon Alpha-2b in Patients With Ano-Genital Warts
11. Enobia Pharma Receives FDA Orphan Drug Designation for Hypophosphatasia Product Candidate ENB-0040
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/28/2015)... 2015 Research and ... of the "12th Annual Report and Survey ... to their offering. The 2015 12th ... and Production is the most recent study of ... projected future capacity and production. The report contains ...
(Date:8/28/2015)... Aug. 28, 2015 ... addition of the "Investigation Report on China,s ... offering. Developed by Novo Nordisk, insulin ... an important drug for the treatment of diabetes. ... fast- acting insulin analog, starts working fast and ...
(Date:8/28/2015)... , Aug. 28, 2015 Perrigo Company plc ... the Mylan N.V. ("Mylan") (NASDAQ: MYL ) shareholder ... "Our views of Mylan,s offer to Perrigo ... based on our Board,s careful reflection of the value ... the limited choices that Mylan has allowed its shareholders ...
Breaking Medicine Technology:12th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production 2China Insulin Aspart Market Report 2010-2019 - Developed by Novo Nordisk 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 2Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 3Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 4Perrigo Confident Its Shareholders Will Reject Mylan's Value Destructive Transaction 5
... Scientific Corporation (NYSE: BSX ) will webcast its ... year ended December 31, 2010 on Wednesday, February 2, at ... by Ray Elliott, President and Chief Executive Officer, and Jeff ... The live webcast and archived replay of this call will ...
... 19, 2011 Wolters Kluwer Health today announced ... Medicom to deliver clinical decision support to doctors in ... its healthcare system. The deal allows Wolters Kluwer Health ... drug information business into the rapidly growing China market ...
Cached Medicine Technology:Boston Scientific to Webcast Conference Call Discussing Fourth Quarter and Full Year 2010 Financial Results 2Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom 2Wolters Kluwer Health Enters Joint Venture with China Drug Information Provider Medicom 3
(Date:8/28/2015)... ... August 28, 2015 , ... ... and Best Practices for Compliance, **Presented by FDAnews and GessNet**, Oct. 14-15, ... internationally renowned expert Fubin Wu, has been specifically designed to provide devicemakers ...
(Date:8/28/2015)... ... August 28, 2015 , ... On May 30th, 2015, Best ... sponsor of the “Music With A Mission” benefit concert in Mendon, IL. Held in ... to raise money to support music education programs in the underfunded local school districts ...
(Date:8/28/2015)... ... 2015 , ... “ Frequentz ” was featured on NewsWatch as part of ... the market for iOS, Android, and Windows. Joe Toohey, the host of AppWatch and ... businesses to track product movement from beginning to end. , Businesses benefit greatly from ...
(Date:8/28/2015)... ... August 28, 2015 , ... Medical Solutions, one of the nation’s largest travel ... in Healthcare by Modern Healthcare and will be honored at an awards dinner ... year, the Best Places to Work in Healthcare program recognizes outstanding employers in the ...
(Date:8/28/2015)... ... ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now treating patients with back pain and ... neck pain, stiffness, muscle spasms, and numbness. , Dr. Toumayan received his Bachelor ... to earn his title of Doctor of Chiropractic from the Palmer College of Chiropractic ...
Breaking Medicine News(10 mins):Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 2Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 3Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 4Health News:FDAnews Announces — Software and Cybersecurity Risk Management for Medical Devices: Understanding the FDA’s Position and Best Practices for Compliance, Oct. 14-15 5Health News:New Video Released on "Music With A Mission" Benefit Concert Headlining Artist Cadillac Three & Best Drug Rehabilitation 2Health News:Track Product Movement from Beginning to End with Frequentz 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 2Health News:Medical Solutions Recognized as One of 2015 Best Places to Work in Healthcare 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3
... 2 Diabetes who are at an increased risk of developing ... blindness . New Wesley Research Institute project aims to make ... Diabetes by using community pharmacists. ,Chief investigator of ... this study had the potential to benefit sufferers by enabling ...
... access journal BMC Public Health suggest that the acetaminophen (paracetamol) ... the decade to 2004 , without a change to the ... the UK. young women, Aboriginals and those on social ... Calgary, Canada team led by Dr. Robert Myers used administrative ...
... Sets Out to Weed Through The Jungle of Plans If you ... have been exposed to multiple diet pitches in your life. ... extracts from Indonesia has been pitched to the greater community at ... called diet plans that often lead to nothing but frustration. ...
... at high-risk of having a heart attack are unclear about ... call an ambulance , argue a group of heart specialists ... people who die from coronary heart disease have had previous ... Heart Foundation shows that 40% of the general population would ...
... University engineers are working to make the traffic control boxes ... developed new software that helps the computerized boxes locate road ... notify transportation authorities at lower cost, especially in rural areas. ... savings could add up to tens of thousands of dollars ...
... sickening erotica fantasies, two US teenagers in the Florida state ... woman, forcing her 12-year-old son to join the outrage , ... ,Authorities allege Avion Lawson, 14, and Nathan Walker, ... who forced their way into the woman's apartment in a ...
Cached Medicine News:Health News:Deep Insights into Type2 Diabetes by Wesley Researchers 2Health News:Overdose of Paracetamol was Dropped 2Health News:Frustrated With Fad Diets One Man Sets Out to Weed Through The Jungle of Plans 2Health News:High-risk Patients Need Better Guidance on What is and Isnt a Heart Attack 2Health News:Traffic Control Boxes to Help Road Monitoring 2Health News:Traffic Control Boxes to Help Road Monitoring 3Health News:Traffic Control Boxes to Help Road Monitoring 4Health News:Traffic Control Boxes to Help Road Monitoring 5Health News:US Teens Charged With Gang Raping a Woman 2Health News:US Teens Charged With Gang Raping a Woman 3
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
... Craftsmanship have produced the finest ... Ocutek® now makes them available ... the coveted Meisterbrief certificate, which ... qualified to become Ocutek instrument ...
... Endoscopic CycloPhotocoagulation (ECP) is a surgical ... endoscopy and visualized laser application. The ciliary ... by the surgeon, from the anterior or ... time. The target tissues are easily and ...
... CycloPhotocoagulation (ECP) is a surgical approach to ... visualized laser application. The ciliary body (which ... surgeon, from the anterior or posterior segment, ... target tissues are easily and accurately identified ...
Medicine Products: